Previous close | 0.2200 |
Open | 0.2200 |
Bid | 0.0000 |
Ask | 0.0000 |
Strike | 60.00 |
Expiry date | 2024-06-21 |
Day's range | 0.2200 - 0.2200 |
Contract range | N/A |
Volume | |
Open interest | N/A |
In this article, we will be taking a look at the 20 biggest health care companies in Australia, 2024. If you do not want to learn about the global healthcare market, head straight to the 5 Biggest Health Care Companies in Australia, 2024. In 2024, Australia’s healthcare landscape will be dominated by a myriad of […]
Gilead Sciences (GILD) closed the most recent trading day at $72.58, moving -0.04% from the previous trading session.
FOSTER CITY, Calif., March 22, 2024--Gilead Sciences, Inc. (Nasdaq: GILD) today announced the completion of the previously announced transaction to acquire CymaBay Therapeutics, Inc. (Nasdaq: CBAY) for approximately $4.3 billion in total equity value. The addition of CymaBay’s investigational lead product candidate, seladelpar for the treatment of primary biliary cholangitis (PBC) including pruritus, complements Gilead’s existing liver portfolio and aligns with its long-standing commitment to br